You are here

Global Health

Primary tabs

The mission of the Global Health Working Group is to explore and improve current and emerging states of health and human security worldwide.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 
Group description: 
This Working Group is focused on exploring current and emerging states of health and human security worldwide.
Group roles and permissions: 
Use default roles and permissions
Group visibility: 
Public - accessible to all site users

Members

Aboubacar Conte admin Albert Gomez Allan Anthony Carrielaj
Chisina Kapungu ChrisAllen Corey Watts CPetry DeannaPolk Elhadj Drame
Gavin Macgregor... Hadiatou Balde hank_test jranck JSole Kathy Gilbeaux
Lisa Stelly Thomas loguest Maeryn Obley mdmcdonald MDMcDonald_me_com Mika Shimizu
mike kraft njchapman Norea Tiaji Salaam-Blyther tnovotny

Email address for group

What worries scientists about bird flu's spread among cattle

The unlikely spread among cattle and one dairy worker has scientists looking through the data to better understand this spillover. They say the risk to humans hinges on whether the virus can evolve in key ways to better infect mammals.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pregnant women's drop in confidence over COVID vaccines outlined in survey

A new study details dramatically lower confidence in COVID-19 vaccine safety in pregnant and recently pregnant women in 2023 compared to 2021, despite evidence to the contrary, according to findings published yesterday in JAMA Network Open.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Characteristics of family practice doctors who see largest share of unvaccinated patients --Canadian study

A study today in CMAJ describes the characteristics of family practice physicians who see the largest share of patients unvaccinated against COVID-19, and reveals that the largest percentage practice in marginalized, lower-income neighborhoods. 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday.

...

 

 

 

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 1.263 seconds.